Construction method of specific chromatogram of paniculate swallowwort root medicinal material or aqueous extract thereof and identification method of paniculate swallowwort root medicinal material or aqueous extract thereof

Through ultrasonic extraction and ether extraction combined with high performance liquid chromatography analysis, a characteristic map of Xu Changqing medicinal materials containing multiple common peaks was constructed, which solved the problem of small number of characteristic peaks and limited identification components in the prior art, and improved medicinal materials and water extracts The identification accuracy ensures the safety of medication.

CN118937506AActive Publication Date: 2024-11-12GUANGDONG YIFANG PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310542351.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-12
Estimated Expiration
2043-05-12

AI Technical Summary

Technical Problem

The existing Xu Changqing medicinal material feature map construction method has a small number of characteristic peaks, limited identification ingredients to saccharophorol, and lacks specific attributes, making it difficult to effectively identify Xu Changqing medicinal materials and their water extracts, resulting in drug safety risks.

Method used

Ultrasonic extraction and ether extraction methods were used, combined with high-performance liquid chromatography analysis, and characteristic maps containing 11 common peaks were constructed. The specificity and identification ability of the map were improved by gradient elution of components such as parahydroxyacetophenone.

Benefits of technology

It achieves a more objective reflection of the chemical characteristics of Xu Changqing medicinal materials or its water extracts, improves the accuracy and specificity of identification, and ensures the safety of Xu Changqing medicinal materials and their preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937506A_ABST
    Figure CN118937506A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine detection and analytical chemistry, in particular to a construction method and an identification method of a specific chromatogram of a paniculate swallowwort root medicinal material or an aqueous extract thereof. According to the technical scheme, the method comprises the steps that a test sample is extracted with water and diethyl ether, the prepared test sample is analyzed through ultra-high performance liquid chromatography, and according to the mobile phase condition, methanol serves as a mobile phase A, a phosphoric acid aqueous solution with the volume concentration of 0.04%-0.06% serves as a mobile phase B, and gradient elution is conducted. The specific chromatogram provided by the invention has better specificity, can well reflect the characteristic components of the cynanchum paniculatum medicinal material or the aqueous extract thereof, and provides a basis for identifying the quality, authenticity and the like of the cynanchum paniculatum medicinal material or the aqueous extract thereof.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of traditional Chinese medicine detection and analytical chemistry, and specifically to a method for constructing a characteristic spectrum of Cynanchum chinense or its aqueous extract and a method for identifying the same. Background Art

[0002] Cynanchum paniculatum (Bge.) Kitag. is a plant of Asclepiadaceae. The dried root and rhizome are collected in autumn, impurities are removed, and dried in the shade. It is pungent and warm in nature. It enters the liver and stomach meridians. It has the effects of dispelling wind, removing dampness, relieving pain, and relieving itching. It is used for rheumatic pain, stomach pain, toothache, back pain, pain from falls, rubella, and eczema. Common counterfeit and mixed products of Cynanchum paniculatum include Baiqian, Baiwei, and Asarum. There is also a plant root called "Laoguatou" that appeared a few years ago, which has seriously affected the market transaction of Cynanchum paniculatum and brought huge safety risks to people's use of medicine.

[0003] Traditional Chinese medicine fingerprint is a comprehensive and quantifiable identification method. It is based on the systematic study of the chemical components of traditional Chinese medicine and is mainly used to evaluate the authenticity, quality and stability of traditional Chinese medicine and semi-finished products of traditional Chinese medicine preparations. Some literature has reported the construction method of HPLC fingerprint of Cynanchum chinense, but the spectra obtained by these methods generally have the defects of small number of characteristic peaks and limited identification of components to paeonol. In addition, the characteristic peak separation, recognizability and specificity of these spectra also need to be improved.

[0004] At present, the provincial local standards for the characteristic spectrum of Xu Changqing Chinese medicine formula granules are mainly divided into three categories: one is the Zhejiang Provincial Standard, which stipulates that its characteristic spectrum includes 6 characteristic peaks and identifies taxifolin and paeonol, but there is no report that Xu Changqing contains taxifolin; the second is the Shanghai Local Standard, which stipulates that its characteristic spectrum includes 6 characteristic peaks and identifies paeonol; the third is the provincial local standard, which stipulates that its characteristic spectrum includes 4 characteristic peaks and identifies paeonol.

[0005] Paeonol is an active ingredient extracted and separated from the dry roots and rhizomes of Cynanchum chinense, a plant of the Asclepiadaceae family, or the root barks of the peony and peony, plants of the genus Paeonia of the family Ranunculaceae. Paeonol has a wide range of pharmacological effects, including sedation, antipyretic, hypnotic, anti-inflammatory, anti-allergic, anti-tumor, immunomodulatory, antioxidant and cardiovascular protection. However, paeonol is not a specific component of Cynanchum chinense, so in the process of establishing the characteristic / fingerprint spectrum of Cynanchum chinense, simply identifying paeonol is not enough to comprehensively characterize the main components of Cynanchum chinense. The content and determination of paeonol in Cynanchum chinense have been specified in the above three standards and the Chinese Pharmacopoeia. It can be seen that when constructing the characteristic spectrum of Cynanchum chinense, more attention should be paid to other representative components other than paeonol to improve its specificity.

[0006] The water extract of Cynomorium fortunei is one of the important raw materials for Chinese medicine preparations such as Chinese patent medicines and Chinese medicine formula granules. Since it has lost the characteristics of the medicinal material, it cannot be effectively identified. Therefore, there is an urgent need to provide a characteristic / fingerprint method that can effectively identify Cynomorium fortunei and the water extract of Cynomorium fortunei that has lost the characteristics of the medicinal material, so as to ensure the safety of the use of Cynomorium fortunei and its related preparations. Summary of the invention

[0007] In view of this, the technical content of this application is specially proposed.

[0008] One of the purposes of the present application is to provide a method for constructing a characteristic spectrum of Cynomorium Changxin medicinal material or its aqueous extract, which fully considers the main volatile or semi-volatile components in Cynomorium Changxin, improves the specificity of the method, and can more objectively reflect the chemical characteristic information of Cynomorium Changxin medicinal material or its aqueous extract; another purpose of the present application is to provide a method for identifying the characteristic spectrum of Cynomorium Changxin medicinal material or its aqueous extract, which can be used to identify the source, quality, authenticity, etc. of Cynomorium Changxin medicinal material or its aqueous extract.

[0009] The specific technical solutions are described below:

[0010] A method for constructing a characteristic spectrum of Cynanchum cyrtonema or its aqueous extract comprises the following steps:

[0011] Providing a test solution, the step of providing the test solution comprising: taking a test sample, adding a first extracting solution to perform a first extraction, separating the solid and the liquid to obtain a liquid, adding a second extracting solution to the liquid to perform a second extraction,

[0012] Wherein, the test sample is selected from Cynanchum chinense and water extract of Cynanchum chinense.

[0013] The first extraction liquid includes water, the first extraction method includes ultrasound,

[0014] The second extracting solution includes ether, and the second extraction method includes extraction;

[0015] Providing a reference solution, wherein the reference substance in the reference solution includes a p-hydroxyacetophenone standard;

[0016] The test solution and the reference solution were respectively subjected to high performance liquid chromatography analysis.

[0017] The conditions of the HPLC analysis include: using methanol as mobile phase A and using a phosphoric acid aqueous solution with a volume concentration of 0.04% to 0.06% as mobile phase B for gradient elution.

[0018] The gradient elution procedure includes: from 0 to 5 minutes, the volume percentage of the mobile phase A is maintained at 14%, from 5 minutes to 10 minutes, the volume percentage of the mobile phase A is increased from 14% to 20%, from 10 minutes to 60 minutes, the volume percentage of the mobile phase A is maintained at 20%, and from 60 minutes to 65 minutes, the volume percentage of the mobile phase A is increased from 20% to 70%.

[0019] A method for identifying Cynanchum chinense medicinal material or its aqueous extract, comprising the following steps:

[0020] Providing a solution of the substance to be tested, wherein the step of providing the solution of the substance to be tested comprises: taking the substance to be tested, adding a first extracting solution to perform a first extraction, separating the solid from the liquid to obtain a liquid, and adding a second extracting solution to the liquid to perform a second extraction,

[0021] Wherein, the analyte is selected from Cynanchum chinense and its water extract.

[0022] The first extraction liquid includes water, the first extraction method includes ultrasound,

[0023] The second extracting solution includes ether, and the second extraction method includes extraction;

[0024] Take a standard of Cynanchum chinense or its aqueous extract, prepare a characteristic spectrum of the standard and a characteristic spectrum of the object to be tested according to the method for constructing a characteristic spectrum according to any one of claims 1 to 6, compare the characteristic spectrum of the standard with the characteristic spectrum of the object to be tested,

[0025] The conditions of the HPLC analysis include: using methanol as mobile phase A and using a phosphoric acid aqueous solution with a volume concentration of 0.04% to 0.06% as mobile phase B for gradient elution.

[0026] The gradient elution procedure includes: from 0 to 5 minutes, the volume percentage of the mobile phase A is maintained at 14%, from 5 minutes to 10 minutes, the volume percentage of the mobile phase A is increased from 14% to 20%, from 10 minutes to 60 minutes, the volume percentage of the mobile phase A is maintained at 20%, and from 60 minutes to 65 minutes, the volume percentage of the mobile phase A is increased from 20% to 70%. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] In order to more clearly illustrate the specific implementation methods of the present application or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0028] Figure 1 It is a comparison chart of the chromatograms obtained by detecting the Radix Cynanchum in different extraction methods in 2.1.1 of Example 1;

[0029] Figure 2 It is a comparison chart of the chromatograms obtained by detecting the Cynanchum chinense medicinal material under different extraction solvents in 2.1.2 of Example 1;

[0030] Figure 3 It is a comparison chart of the chromatograms obtained by detecting the Cynanchum chinense medicinal material under different mobile phase conditions in 3.1 of Example 1;

[0031] Figure 4 It is a comparison chart of the chromatograms obtained by detecting the Radix Cynanchum in 3.2 of Example 1 under different elution gradient conditions;

[0032] Figure 5 It is a comparison chart of the chromatograms obtained by detecting the Radix Cynanchum in 3.3 of Example 1 under different chromatographic column conditions;

[0033] Figure 6 It is an overlay of the chromatograms obtained from the detection of 15 batches of Radix Cynanchifoliae medicinal materials in 4 of Example 1;

[0034] Figure 7 The characteristic spectrum of the Radix Cynanchum obtained in 4 of Example 1;

[0035] Figure 8 It is the characteristic spectrum of the standard product of Radix Cynanchifoliae used for comparison in 4 of Example 1;

[0036] Fig. 9 It is an overlay of the chromatograms obtained by detecting 15 batches of Cynanchum chinense aqueous extracts in 2.3 of Example 2;

[0037] Fig.10 The characteristic spectrum of the water extract of Cynanchum chinense obtained in 2.3 of Example 2;

[0038] Fig.11 It is a comparison diagram of the total ion flow diagram and the ultraviolet absorption chromatogram of the Cynanchum chinense medicinal material test solution in 2.2 of Example 3;

[0039] Fig.12 It is a comparison diagram of the retention time of the characteristic spectrum chromatographic peak of Cynanchum chinense in 2.3 in Example 3 and the reference substance;

[0040] Fig.13 It is a comparison diagram of the characteristic spectrum chromatographic peak of Cynanchum chinense in 2.3 of Example 3 and the ultraviolet absorption curve of the reference substance;

[0041] Fig.14 It is a comparison chart of the characteristic spectra of the Radix Cynanchifolia and the counterfeit product in 1 of Example 4;

[0042] Fig.15 It is a comparison chart of the characteristic spectra of the water extract of Cynanchum chinense and the counterfeit product in 2 of Example 4;

[0043] Fig.16 16A is a comparison diagram of the characteristic spectra measured under the comparative chromatographic conditions of comparative example 1, wherein 16A is a comparison diagram of the detection results under comparative chromatographic conditions 1 to 3, and 16B is a comparison diagram of the detection results under comparative chromatographic conditions 4 to 7. DETAILED DESCRIPTION

[0044] The present application will be further described below in conjunction with the embodiments, examples and accompanying drawings. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. In addition, it should be understood that after reading the content taught in the present application, those skilled in the art may make various changes or modifications to the present application, and these equivalent forms also fall within the scope of protection of the claims attached to the present application.

[0045] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit this application.

[0046] the term

[0047] Unless otherwise specified or incompatible herewith, the terms and phrases used herein shall have the following meanings:

[0048] The Chinese medicinal materials referred to in this application include pure medicinal materials and Chinese medicinal preparations obtained by further cutting and roasting the pure medicinal materials.

[0049] The aqueous extracts of Chinese medicinal materials referred to in this application include their standard decoctions and Chinese medicinal formula granules.

[0050] The standard decoction in this application is a single-flavor Chinese medicine decoction prepared by standardized process with reference to modern extraction methods and guided by traditional Chinese medicine theory and based on clinical application. The Chinese medicine formula granules in this application are a series of pure Chinese medicine products refined by modern pharmaceutical technology extraction, concentration, separation, drying, granulation, packaging, etc. using traditional Chinese medicine pieces that meet the processing specifications as raw materials. It can be understood that the above-mentioned standard decoctions and Chinese medicine formula granules can basically guarantee all the characteristics of the original Chinese medicine pieces.

[0051] The standard products of Chinese medicinal materials referred to in this application are control medicinal materials sold by the China Food and Drug Inspection Institute or working control medicinal materials inspected by provincial and municipal drug inspection institutes.

[0052] The term "and / or" used in this article includes any one of two or more related listed items, and also includes any and all combinations of related listed items, and the arbitrary and all combinations include any two related listed items, any more related listed items, or all related listed items. It should be noted that when at least three items are connected by at least two conjunctions selected from "and / or", it should be understood that in this application, the technical solution undoubtedly includes technical solutions that are all connected by "logical and", and undoubtedly includes technical solutions that are all connected by "logical or". For example, "A and / or B" includes three parallel solutions of A, B and A+B. For example, the technical solution of "A, and / or, B, and / or, C, and / or, D" includes any one of A, B, C, and D (that is, the technical solution that is all connected by "logical OR"), and also includes any and all combinations of A, B, C, and D, that is, the combination of any two or any three of A, B, C, and D, and also includes the combination of four of A, B, C, and D (that is, the technical solution that is all connected by "logical AND").

[0053] Herein, "preferred", "preferable", "better", etc. are only used to describe implementation methods or examples with better effects. It should be understood that they do not constitute limitations on the scope of protection of this application.

[0054] In the present application, "further", "further", "particularly" and the like are used for descriptive purposes to indicate differences in content, but should not be construed as limiting the scope of protection of the present application.

[0055] In the present application, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0056] In the present application, when it comes to numerical intervals (i.e., numerical ranges), unless otherwise specified, the optional numerical distribution is considered continuous within the above numerical interval, and includes the two numerical endpoints (i.e., the minimum and maximum values) of the numerical range, and each numerical value between the two numerical endpoints. Unless otherwise specified, when the numerical interval only refers to integers within the numerical interval, it includes the two endpoint integers of the numerical range, and each integer between the two endpoints. In addition, when multiple ranges are provided to describe features or characteristics, these ranges can be combined. In other words, unless otherwise specified, the ranges disclosed herein should be understood to include any and all subranges included therein.

[0057] The temperature parameters in this application, unless otherwise specified, are allowed to be either constant temperature treatment or to vary within a certain temperature range. It should be understood that the constant temperature treatment allows the temperature to fluctuate within the accuracy range controlled by the instrument. Fluctuations within the range of ±0.5°C, ±0.4°C, ±0.3°C, ±0.2°C, and ±0.1°C are allowed.

[0058] In the present application, weight may be μg, mg, g, kg or other mass units known in the chemical industry.

[0059] Construction of the characteristic map of Radix Cynanchum chinense:

[0060] In one aspect of the present application, a method for constructing a characteristic spectrum of Cynanchum chinense medicinal material or its aqueous extract is provided. The method has the advantages of stability, good precision and good reproducibility, and the method has good specificity and can more objectively reflect the characteristic information of Cynanchum chinense medicinal material or its aqueous extract.

[0061] In one embodiment, a method for constructing a characteristic spectrum of Cynanchum chinense or its aqueous extract comprises the following steps:

[0062] Providing a test solution, the steps of providing the test solution comprising: taking a test sample, adding a first extracting solution to perform a first extraction, separating the solid and the liquid to obtain a liquid, adding a second extracting solution to the obtained liquid to perform a second extraction,

[0063] The test samples were selected from Cynanchum chinense and its water extract.

[0064] The first extraction liquid includes water, the first extraction method includes ultrasound,

[0065] The second extracting solution includes ether, and the second extraction method includes extraction;

[0066] providing a reference solution, wherein the reference substance in the reference solution includes a standard of p-hydroxyacetophenone;

[0067] Take the test solution and the reference solution for high performance liquid chromatography analysis.

[0068] The conditions for HPLC analysis include: using methanol as mobile phase A and using a phosphoric acid aqueous solution with a volume concentration of 0.04% to 0.06% as mobile phase B for gradient elution.

[0069] The gradient elution procedure includes: 0-5min, maintaining the volume percentage of mobile phase A at 14%, 5min-10min, increasing the volume percentage of mobile phase A from 14% to 20%, 10min-60min, maintaining the volume percentage of mobile phase A at 20%, 60min-65min, increasing the volume percentage of mobile phase A from 20% to 70%.

[0070] In one embodiment, the conditions for HPLC analysis also include at least one of the following features:

[0071] (1) The chromatographic column is filled with octadecylsilane bonded silica gel, (2) the column temperature is 28°C to 32°C, (3) the detection wavelength is 270 nm to 280 nm, (4) the flow rate of the mobile phase is 0.55 mL / min to 0.65 mL / min, and (5) the injection volume is 4 μl to 6 μl.

[0072] In one embodiment, in the step of providing the test solution, the power of ultrasound is 200W to 400W and the frequency is 30kHz to 50kHz.

[0073] In one embodiment, in the step of providing the test solution, the solid-liquid separation method includes centrifugation, and further, the centrifugal rotation speed is 3000-5000 rpm.

[0074] In one embodiment, in the step of providing the test solution, the weight volume ratio of the test solution to the first extract is selected from: 0.4-0.6 g / 25 mL or 2-4 g / 25 mL;

[0075] Further, the test sample is selected from the water extract of Chinese medicinal materials and the weight volume ratio of the test sample to the first extract is: 0.4-0.6g / 25mL, or,

[0076] The test sample is selected from Chinese medicinal materials and the weight volume ratio of the test sample to the first extract is 2 to 4 g / 25 mL.

[0077] In one embodiment, in the step of providing the test solution, the volume ratio of the liquid obtained by solid-liquid separation and the second extract is 25:(40-60).

[0078] In one embodiment, the aqueous extract of Cynanchum chinense medicinal material includes a standard decoction of Cynanchum chinense medicinal material and a Chinese medicine formula granule of Cynanchum chinense medicinal material.

[0079] In one embodiment, the aqueous extract of Cynanchum chinense is prepared by the following preparation steps:

[0080] Take a Radix Cynanchum and soak it in water, add a first solvent to perform a first decoction, the weight ratio of the first solvent to the Radix Cynanchum is (10-12):1, filter to obtain a first filtrate and a filter residue, add a second solvent to the filter residue to perform a second decoction, the weight ratio of the second solvent to the Radix Cynanchum is (8-10):1, filter to obtain a second filtrate, and combine the first filtrate and the second filtrate;

[0081] The first solvent is water, the first decoction time is 20 to 30 minutes,

[0082] The second solvent is water, and the second decoction time is 10 to 20 minutes.

[0083] In one embodiment, the characteristic spectrum of the Cynanchum chinense medicinal material or its aqueous extract constructed includes 11 common peaks.

[0084] Among them, taking peak 7 as a reference, the characteristic peaks and their relative retention times are as follows: peak 1: 0.37±10%, peak 2: 0.59±10%, peak 3: 0.67±10%, peak 4: 0.76±10%, peak 5: 0.86±10%, peak 6: 0.91±10%, peak 8: 1.37±10%, peak 9: 1.53±10%, peak 10: 1.70±10%, peak 11: 1.85±10%,

[0085] Among them, peak 2 is p-hydroxybenzoic acid, peak 4 is vanillic acid, peak 7 is p-hydroxyacetophenone, peak 8 is isovillabite, peak 9 is 2,3-dihydroxy-4-methoxyacetophenone, peak 10 is 2,4-dihydroxyacetophenone, and peak 11 is 2,5-dihydroxy-4-methoxyacetophenone.

[0086] Another aspect of the present application relates to a method for identifying Cynanchum chinense medicinal material or its aqueous extract, which is based on the characteristic spectrum construction method described in any of the above-mentioned technical solutions, and the characteristic spectrum of the analyte and the standard is established respectively, and the identification of the analyte is achieved by comparing the characteristic spectrum of the analyte with the characteristic spectrum of the standard.

[0087] In one embodiment, the identification method of Cynanchum chinense medicinal material or its aqueous extract comprises the following steps:

[0088] Providing a solution of the substance to be tested, wherein the steps of providing the solution of the substance to be tested include: taking the substance to be tested, adding a first extracting solution to perform a first extraction, performing solid-liquid separation to obtain a liquid, and adding a second extracting solution to the obtained liquid to perform a second extraction,

[0089] Wherein, the analyte is selected from one or both of Cynanchum chinense and water extract of Cynanchum chinense.

[0090] The first extraction liquid includes water, the first extraction method includes ultrasound,

[0091] The second extracting solution includes ether, and the second extraction method includes extraction;

[0092] Take a standard of Cynanchum cyrtonema or its aqueous extract, prepare a characteristic spectrum of the standard and a characteristic spectrum of the object to be tested according to the characteristic spectrum construction method described in any of the above technical solutions, compare the characteristic spectrum of the standard with the characteristic spectrum of the object to be tested,

[0093] The conditions for HPLC analysis include: using methanol as mobile phase A and using a phosphoric acid aqueous solution with a volume concentration of 0.04% to 0.06% as mobile phase B for gradient elution.

[0094] The gradient elution procedure includes: 0-5min, maintaining the volume percentage of mobile phase A at 14%, 5min-10min, increasing the volume percentage of mobile phase A from 14% to 20%, 10min-60min, maintaining the volume percentage of mobile phase A at 20%, 60min-65min, increasing the volume percentage of mobile phase A from 20% to 70%.

[0095] It is understandable that the characteristic spectrum obtained by detecting the test solution by ultra-high performance liquid chromatography can be analyzed as needed. For example, a single test sample is tested and compared with the characteristic spectrum established by the characteristic spectrum construction method of the Radix Cynanchifolia or its aqueous extract described in any of the above technical solutions to obtain the quality of the single test sample; or multiple batches of test samples are tested, and the spectra of the multiple batches of test samples are compared with each other to obtain the similarity between the multiple batches of test samples.

[0096] It can be understood that the method for constructing the characteristic spectrum of the standard or the test object in the above-mentioned identification method is similar to the method for constructing the characteristic spectrum of the Xu Changqing medicinal material or its water extract described in any of the above-mentioned technical schemes, and the method for preparing the test solution is the same as the method for preparing the test solution described in any of the above-mentioned technical schemes, which will not be repeated here.

[0097] The following are some specific embodiments.

[0098] Example 1

[0099] This embodiment is about the exploration and establishment of the characteristic spectrum of Radix Cynanchifoliae and its construction method, and the specific steps are as follows:

[0100] 1. Instruments and reagents for drug testing

[0101] 1.1. Instrument

[0102] High performance liquid chromatography (Arc, Waters Corporation); Welch C18 chromatographic column (4.6×250 mm, 2.7 μm); one-tenth balance (ME204E, Mettler-Toledo), one-millionth balance (XP26, Mettler-Toledo), CNC ultrasonic cleaner (KQ500D, Kunshan Ultrasonic Instrument Co., Ltd.), constant temperature water bath (HWS28, Shanghai Yiheng Technology Co., Ltd.), ultrapure water system (Milli-Q Direct, Merck Co., Ltd.).

[0103] 1.2. Reagents

[0104] Ethanol (Tianjin Yongda Chemical Reagent Co., Ltd.) and methanol (Guangdong Guanghua Technology Co., Ltd.) were of analytical grade, methanol and acetonitrile (Merck Co., Ltd.) were of chromatographic grade, and water was ultrapure water (self-made in the laboratory).

[0105] 1.3. Drug testing

[0106] Reference herbal medicine of Cynanchum chinense (batch number: 121514-201202, China Food and Drug Inspection Institute); p-hydroxyacetophenone (batch number: 111897-201602, content: 99.9%, China Food and Drug Inspection Institute). The herbal medicine information of Cynanchum chinense is shown in Table 1:

[0107] Table 1 Source information of 15 batches of Cynanchum cyrtonema

[0108]

[0109] 2. Sample Preparation

[0110] 2.1. Preparation of test solution

[0111] 2.1.1. Investigation of extraction methods

[0112] This experiment investigated the effects of different extraction methods on the characteristic spectrum of the medicinal material Cynanchum cyrtonema. Two extraction methods, direct aqueous solution ultrasound and extraction, were investigated. The effects of different extraction methods on the characteristic spectrum of the medicinal material Cynanchum cyrtonema were compared by comparing the peak shapes and separation degrees of 11 characteristic peaks.

[0113] ① Take about 3g of crude powder of Cynanchum chinense (G1901091), place it in a stoppered conical flask, add 25mL of water, and ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, cool, shake well, filter, and take the filtrate to obtain.

[0114] ②Take about 3g of crude powder of Cynanchum chinense (G1901091), place it in a stoppered conical flask, add 25mL of water, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, cool, centrifuge (4000 rpm) for 5 minutes, extract the supernatant twice with ether, 25mL each time, combine the ether liquid, evaporate to dryness, dissolve the residue in methanol, dilute to 5mL, shake well, filter, and take the filtrate. The experimental results are shown in Figure 1 .

[0115] The results showed that the peak shape and separation effect of each characteristic peak were significantly different when different extraction methods were used. The use of aqueous solution ultrasonic extraction resulted in more impurities, poor chromatographic peak separation, and uneven baseline. Ether was used for extraction and purification after ultrasonic treatment. After purification, the chromatographic peak response was high, the separation was good, and there were few impurities. Therefore, in order to ensure the overall effect of the characteristic spectrum, aqueous solution ultrasonic treatment followed by ether extraction was selected as the extraction method for the characteristic spectrum of Cynanchum cyrtonema.

[0116] 2.1.2. Extraction solvent investigation

[0117] This experiment investigated the effects of different extraction solvents on the characteristic spectrum of Cynanchum cyrtonema. Dichloromethane, ether and ethyl acetate were used as extraction solvents. The peak shapes and separations of 11 characteristic peaks were used to compare the effects of different extraction solvents on the characteristic spectrum of Cynanchum cyrtonema.

[0118] Take about 3g of crude powder of Radix Cynanchum (G1901091), place in 3 parallel groups, put in a stoppered conical flask, add 25mL of water, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, cool, centrifuge (4000 rpm) for 5 minutes, extract the supernatant twice with dichloromethane, ether, and ethyl acetate, 25mL each time, combine the extracts, evaporate to dryness, dissolve the residue in methanol, dilute to 5mL, shake well, filter, and take the filtrate. Results are shown in Figure 2 .

[0119] The results showed that among the three extraction solvents, the characteristic spectrum of dichloromethane extraction lacked some features and the overall response was low, so dichloromethane was not selected as the extraction solvent for the time being; the chromatograms, responses and separations obtained by ethyl acetate and ether extraction were not much different, and both had 11 characteristic peaks. However, since the evaporation time of ethyl acetate was too long, heating and evaporation would destroy the volatile oil compounds in Cynanchum cyrtonema, including acetophenones and phenolic compounds, which was not conducive to the experiment. Therefore, ether was selected as the extraction solvent.

[0120] 2.1.3 Establishment of the test solution preparation method

[0121] Take about 3 g of crude powder of this product, place it in a stoppered conical flask, add 25 mL of water, ultrasonically treat (power 300 W, frequency 40 kHz) for 30 minutes, cool, centrifuge (4000 rpm) for 5 minutes, extract the supernatant twice with ether, 25 mL each time, combine the ether solutions, evaporate to dryness, dissolve the residue in methanol, make up to 5 mL, shake well, filter, and take the filtrate to obtain the product.

[0122] 2.2. Preparation of reference solution and reference substance solution

[0123] Take 3 g of Cynanchum chinense reference medicinal material, place it in a stoppered conical flask, add 25 ml of water, ultrasonically treat (power 300 W, frequency 40 kHz) for 30 minutes, take it out, cool, centrifuge (4000 rpm) for 5 minutes, extract the supernatant twice with ether, 25 mL each time, combine the ether solutions, evaporate to dryness, dissolve the residue in methanol, make up to 5 mL, shake well, filter, and take the filtrate as the reference solution of Chinese medicinal materials.

[0124] Take an appropriate amount of p-hydroxyacetophenone reference substance, weigh it accurately, and add methanol to make a solution containing 10 μg per 1 ml, which serves as the reference solution of the standard substance.

[0125] 3. Determination of chromatographic conditions

[0126] This section examines the effects of different chromatographic conditions (mobile phase, chromatographic column, column temperature, elution procedure, etc.) on the characteristic spectrum of Cynanchum chinense, and establishes chromatographic conditions based on the investigation results.

[0127] 3.1. Mobile phase conditions

[0128] High performance liquid chromatography (Arc, Waters Corporation); C18 chromatographic column (4.6×250mm, 2.7μm); using the methanol-0.05% phosphoric acid system and elution procedure in Example 1, acetonitrile-0.05% phosphoric acid, methanol-0.05% triethylamine, and methanol-water systems were compared, and elution was performed according to the same elution procedure in Table 2; the column temperature was 30°C, the flow rate was 0.60ml per minute, and the detection wavelength was 274nm. Figure 3 .

[0129] Table 2 Gradient elution table

[0130]

[0131]

[0132] The results show that compared with the mobile phase system of the present application (methanol-0.05% phosphoric acid), the number of common chromatographic peaks using the methanol-water system will be reduced, and some components will not be reflected, which is not representative enough; using the acetonitrile-0.05% phosphoric acid system, since acetonitrile has a stronger elution ability than methanol, most components have a short retention time and are eluted before being completely separated, which does not meet the requirements of the characteristic spectrum; using the methanol-0.05% triethylamine system, there are even fewer chromatographic peaks, so it is not used for the time being.

[0133] 3.2. Different elution gradients

[0134] High performance liquid chromatography (Arc, Waters Corporation); Welch C18 (4.6×250mm, 2.7μm); the characteristic spectrum effects obtained by different elution procedures were compared using the methanol-0.05% phosphoric acid system and elution gradient in Example 1, the column temperature was 30°C, the flow rate was 0.60ml per minute, and the detection wavelength was 274nm. Figure 4 .

[0135] Table 3 Gradient elution table ①

[0136]

[0137] Table 4 Gradient elution table ②

[0138]

[0139] Table 5 Gradient elution table ③

[0140]

[0141] The results showed that compared with the gradient elution program (gradient ③) of the present application, using the other two gradient elution programs (gradients ① and ②), fewer chromatographic peaks were obtained in the first 30 minutes of elution of the chromatogram, and in the next 30 minutes, the elution gradient was faster, which affected the separation of the chromatographic peaks. The overall effect was not as good as gradient ③. The method established in the present application eluted 11 chromatographic peaks within 1 hour, and the overall distribution of retention time was relatively appropriate. Each chromatographic peak achieved baseline separation. Therefore, gradient ③ was selected as the elution program for the characteristic spectrum of Xu Changqing.

[0142] 3.3. Chromatographic columns

[0143] The XCQ11 test solution in Example 1 was taken, and the characteristic spectrum of the Cynanchum chinense medicinal material was determined using different chromatographic columns according to the chromatographic conditions in 3.1.

[0144] High performance liquid chromatograph (Arc, Waters Corporation); Agilent ZORBAX SB-C18 chromatographic column (4.6×250 mm, 5 μm), Thermo Acclaim 120C18 chromatographic column (4.6×250 mm, 5 μm), Waters Xselect HSS T3 chromatographic column (4.6×250 mm, 5 μm); using the same methanol-0.05% phosphoric acid system and elution procedure, column temperature, flow rate, detection wavelength and other chromatographic conditions as in Example 1, the separation effects of different chromatographic columns were compared, see Figure 5 .

[0145] The results showed that, with Welch Compared with C18 columns, Agilent ZORBAX SB-C18 columns, Thermo Acclaim 120C18 columns, and Waters Xselect HSS T3 columns all fail to achieve ideal chromatographic peak separation effects, and have less chromatographic peak information. Therefore, Welch The characteristic spectrum of Cynanchum paniculatum was detected by C18 chromatographic column.

[0146] 3.4. Established chromatographic conditions

[0147] Welch C18 chromatographic column (column length 250mm, inner diameter 4.6mm, particle size 2.7μm), methanol as mobile phase A, 0.05% phosphoric acid solution as mobile phase B, gradient elution according to Table 5; column temperature 30℃, flow rate 0.60ml per minute, detection wavelength 274nm. The theoretical plate number should be not less than 5000 based on the p-hydroxyacetophenone peak.

[0148] 4. Construct feature map

[0149] The “Chinese Medicine Chromatographic Characteristic Spectrum Similarity Evaluation System (2012.0 Version)” was used to process the data of 15 batches of Cynanchum chinense medicinal material samples and generate superimposed spectra. Figure 6 , 11 common peaks with relatively stable relative retention time and relative peak area RSD were selected as characteristic peaks, and the control characteristic spectrum was generated as shown in Figure 7 .

[0150] Table 6 Characteristic spectra of 15 batches of Cynanchum chinense (relative retention time)

[0151]

[0152] Table 7 Characteristic spectra of 15 batches of Cynanchum chinense (relative peak area)

[0153]

[0154]

[0155] Table 8 Calculation results of similarity of characteristic spectra of 15 batches of Cynanchum cyrtonema

[0156]

[0157] The results showed that the characteristic spectra of 15 batches of Cynanchum cyrtonema had 11 common peaks, and the similarity was greater than 0.99 (Table 8), which was consistent with the chromatographic peaks of Cynanchum cyrtonema reference medicinal materials provided by the China Food and Drug Inspection Institute (see Figure 8 ), indicating that the 11 common peaks established by this method are all components of Cynanchum cynanchum. Taking peak 7 p-hydroxyacetophenone as the reference peak, the RSD values ​​of the relative retention time of the other 10 characteristic peaks of the characteristic spectrum of 15 batches of Cynanchum cynanchum medicinal materials are between 0.03% and 0.12%, which meets the standard requirements of the characteristic spectrum of Cynanchum cynanchum medicinal materials; the RSD of the relative peak area of ​​the 10 characteristic peaks of the characteristic spectrum of 15 batches of Cynanchum cynanchum medicinal materials is between 11.81% and 43.94%. The results show that there are certain differences in the corresponding components of the characteristic peaks of Cynanchum cynanchum medicinal materials from different origins, so the relative peak area is not specified for the time being.

[0158] Therefore, the characteristic spectrum standard of Xu Changqing medicinal material is stipulated as follows: 11 characteristic peaks should be present in the chromatogram of the test sample, and the retention time should correspond to the 11 characteristic peaks in the chromatogram peaks of the reference medicinal material, among which Peak 7 should be consistent with the retention time of the reference peak of the reference substance. The peak corresponding to the peak of the reference substance of para-hydroxyacetophenone is the S peak. The relative retention time of each characteristic peak and the S peak is calculated. The relative retention time should be within the range of ±10% of the specified value. The specified values ​​are: 0.37 (peak 1), 0.59 (peak 2), 0.67 (peak 3), 0.76 (peak 4), 0.86 (peak 5), 0.91 (peak 6), 1.37 (peak 8), 1.53 (peak 9), 1.70 (peak 10), 1.85 (peak 11).

[0159] Example 2

[0160] This embodiment is the construction of the characteristic spectrum of the water extract of the medicinal material Cynanchum cyrtonema. In the construction method of this application, the conditions such as instruments, materials, chromatographic conditions, and preparation of reference solutions refer to Example 1, and the remaining steps are detailed below.

[0161] 2.1. Preparation of aqueous extracts

[0162] Take the Radix Cynanchum and prepare them into slices, soak them for 30 minutes, add water and decoct them twice, add 11 times the amount of water for the first decoction, decoct for 20 minutes, and filter the decoction through a 350-mesh sieve while hot. Add 9 times the amount of water for the second decoction, decoct for 15 minutes, filter the decoction through a 350-mesh sieve while hot, quickly cool the filtrate with cold water, combine the two decoctions, transfer to a vacuum freeze dryer for freeze drying, and take out to obtain the decoction.

[0163] 2.2. Preparation of test solution

[0164] Take an appropriate amount of this product, grind it into powder, take about 0.5g, put it in a stoppered conical flask, add 25mL of water, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, cool, centrifuge (4000 rpm) for 5 minutes, extract the supernatant twice with ether, 25mL each time, combine the ether solutions, evaporate to dryness, dissolve the residue in methanol, make up to 5mL, shake well, filter, and take the filtrate to obtain the product.

[0165] 2.3. Establishment of feature maps

[0166] The “Chinese Medicine Chromatographic Characteristic Spectrum Similarity Evaluation System (2012.0 Version)” was used to process the data of 15 batches of Cynanchum cyrtonema water extract samples and generate superimposed spectra. Fig. 9 , select 11 common peaks with relatively stable relative retention time and relative peak area RSD as characteristic peaks, and generate a control characteristic spectrum. Fig.10 .

[0167] The characteristic spectra of 15 batches of Cynanchum cyrtonema water extract were analyzed, and the chromatographic peak 7 corresponding to p-hydroxyacetophenone was used as the reference peak S. The relative retention time (Table 9) and relative peak area (Table 10) of other chromatographic peaks were calculated, and the RSD values ​​were calculated. The experimental results are shown below:

[0168] Table 9 Characteristic spectra of 15 batches of Cynanchum chinense aqueous extracts (relative retention time)

[0169]

[0170] Table 10 Characteristic spectra of 15 batches of Cynanchum chinense aqueous extracts (relative peak areas)

[0171]

[0172] The results showed that the characteristic spectra of 15 batches of Cynanchum cyrtonema water extracts had 11 common peaks, which were consistent with the common peaks of the characteristic spectra of Cynanchum cyrtonema medicinal materials.

[0173] Taking peak 7 p-hydroxyacetophenone as the reference peak, the RSD values ​​of the relative retention times of the other 10 characteristic peaks of the characteristic spectra of 15 batches of Cynomorium Changqing water extracts were between 0.06% and 0.12%, which met the standard requirements of the characteristic spectra of Cynomorium Changqing water extracts; the RSD of the relative peak areas of the 10 characteristic peaks of the characteristic spectra of 15 batches of Cynomorium Changqing water extracts were between 10.68% and 30.76%. The results showed that there were certain differences in the corresponding components of the characteristic peaks of the water extracts made from Cynomorium Changqing medicinal materials from different origins, and therefore no regulations were made for the relative peak areas for the time being.

[0174] Therefore, the characteristic spectrum standard of the water extract of Cynanchum cyrtonema is stipulated as follows: 11 characteristic peaks should be present in the chromatogram of the test sample, and the retention time of the 11 characteristic peaks in the chromatogram of the reference medicinal material should correspond to that of the reference material, among which Peak 7 should be consistent with the retention time of the reference material peak. The peak corresponding to the peak of the reference material of para-hydroxyacetophenone is the S peak. The relative retention time of each characteristic peak and the S peak is calculated, and the relative retention time should be within the range of ±10% of the specified value. The specified values ​​are: 0.37 (peak 1), 0.59 (peak 2), 0.67 (peak 3), 0.76 (peak 4), 0.86 (peak 5), 0.91 (peak 6), 1.37 (peak 8), 1.53 (peak 9), 1.70 (peak 10), 1.85 (peak 11). It is consistent with the Cynanchum cyrtonema.

[0175] Example 3

[0176] This embodiment is the identification of the chromatographic peak components of the characteristic spectrum of Cynanchum serrata.

[0177] 1. Instruments and test drugs

[0178] 1.1. Instrument

[0179] Thermo Vanquish Flex ultra-high performance liquid chromatography-Thermo Fisher QE high-resolution mass spectrometer (Thermo Fisher Scientific); high performance liquid chromatography (Arc, Waters Corporation); ultrapure water system (Milli-Q Direct, Merck & Co., Ltd.); 1 / 10,000 balance (ME204E, Mettler-Toledo); CNC ultrasonic cleaner (KQ-500DE, Kunshan Ultrasonic Instrument Co., Ltd.).

[0180] 1.2. Reagents

[0181] Methanol (chromatographic grade, Merck Co., Ltd.); formic acid (LC-MS grade, ≥98.0%, batch number: A8310050, CNW); water is homemade ultrapure water; other reagents are of analytical grade. p-Hydroxybenzoic acid (batch number: 2169, Shanghai Shidande Biotechnology Co., Ltd.); vanillic acid (batch number: 110776-201503, China Food and Drug Inspection Institute); p-Hydroxyacetophenone (batch number: 111897-201602, China Food and Drug Inspection Institute); isovanillyl acetophenone (batch number: 14738, Shanghai Shidande Biotechnology Co., Ltd.); 2,4-dihydroxyacetophenone (batch number: 12713, Shanghai Shidande Biotechnology Co., Ltd.); 2,3-dihydroxy-4-methoxyacetophenone (made in the laboratory); 2,5-dihydroxy-4-methoxyacetophenone (made in the laboratory).

[0182] 1.3. Drug testing

[0183] Take the XCQ11 sample solution in Example 1.

[0184] 2. Mass spectrometry identification

[0185] 2.1. HPLC-MS / MS conditions

[0186] The chromatographic conditions followed the optimal chromatographic conditions established in Example 1. The mass spectrometry parameters are shown in Table 11.

[0187] Table 11 Mass spectrometry parameters

[0188]

[0189] 2.2. Identification of compounds

[0190] The test solution was tested using the above-mentioned liquid chromatography and mass spectrometry analysis conditions. By comparing the precise primary and secondary molecular weights of the mass spectrometry, and comparing the fragment ions, and comparing with the local mass spectrometry database, seven components in the characteristic spectrum of Xu Changqing medicinal materials, including p-hydroxybenzoic acid (peak 2), vanillic acid (peak 4), p-hydroxyacetophenone (peak 7), isovanillic acetophenone (peak 8), 2,3-dihydroxy-4-methoxyacetophenone (peak 9), 2,4-dihydroxyacetophenone (peak 10), and 2,5-dihydroxy-4-methoxyacetophenone (peak 11), were confirmed. The total ion flow diagram and ultraviolet absorption chromatogram of the test solution are shown in Fig.11 The compound identification results are shown in Table 12.

[0191] Table 12 Mass spectrometry identification results of compounds in Cynanchum chinense

[0192]

[0193]

[0194] 2.3. Identification of reference substances

[0195] Take appropriate amounts of p-hydroxybenzoic acid reference substance, vanillic acid reference substance, p-hydroxyacetophenone reference substance, isovanillic acetophenone reference substance, 2,4-dihydroxyacetophenone reference substance, 2,3-dihydroxy-4-methoxyacetophenone reference substance, and 2,5-dihydroxy-4-methoxyacetophenone reference substance, add methanol to prepare reference solution, and analyze according to the chromatographic conditions in Example 1, and compare the retention time ( Fig.12 ) and 3D UV absorption curves ( Fig.13 ).

[0196] The results showed that peaks 2, 4, 7, 8, 9, 10 and 11 in the characteristic spectrum of Xu Changqing were consistent with the retention time and 3D ultraviolet absorption curve of p-hydroxybenzoic acid reference, vanillic acid reference, p-hydroxyacetophenone reference, isovillyl acetophenone reference, 2,3-dihydroxy-4-methoxyacetophenone reference, 2,4-dihydroxyacetophenone reference and 2,5-dihydroxy-4-methoxyacetophenone reference, respectively, and the results were consistent with the mass spectrometry identification results.

[0197] Example 4

[0198] This example is to identify Cynanchum chinense and its counterfeit products (Baiwei, Baiqian, Asarum, Laoguatou), including the steps of chromatographic analysis of the above-mentioned test objects (herbal medicines or their water extracts) and the construction of their characteristic spectra. Among them, the preparation of instruments and reagents, chromatographic conditions, and reference solution is the same as in "Example 1". The preparation of the test solution of counterfeit (Baiwei, Baiqian, Asarum, Laoguatou) medicinal materials is the same as in "Example 1", and the preparation of the test solution of the water extract of counterfeit (Baiwei, Baiqian, Asarum, Laoguatou) is the same as in "Example 2". The source information of Baiwei, Baiqian, Asarum, Laoguatou medicinal materials is shown in Table 13.

[0199] Table 13 Information on the sources of medicinal materials of Baiwei, Baiqian, Xixin and Laoguatou

[0200]

[0201]

[0202] 1. Comparison of characteristic spectra of Cynanchum chinense and different counterfeit medicinal materials

[0203] Take Radix Cynanchum and other counterfeit herbs in Table 13, prepare test solution, and then inject and measure. The test results are shown in Fig.14 .

[0204] The results showed that the characteristic spectra of the three batches of Cynanchum cyrtonema had 11 common peaks. The 14 batches of Cynanchum cyrtonema, Baiwei, Baiqian, Asarum, and Laoguatou had five common chromatographic peaks, namely peak 2, peak 4, peak 5, peak 6, and peak 9. Different varieties can be distinguished by the number of chromatographic peaks. For example, Baiqian and Asarum lack peaks 3 and 8. Cynanchum cyrtonema can be distinguished from other types of medicinal materials based on peak 11, which is the characteristic chromatographic peak of Cynanchum cyrtonema.

[0205] 2. Comparison of characteristic spectra of water extracts of Cynanchum chinense and water extracts of different counterfeits

[0206] Take the water extract of Cynanchum chinense and other counterfeit water extracts in Table 13, prepare the test solution and inject it for determination. The results are shown in Fig.15 .

[0207] The results showed that the characteristic spectra of the three batches of water extracts of Cynanchum chinense had 11 common peaks. After water extraction of Cynanchum chinense, Baiwei, Baiqian, Asarum, and Laoguatou, 14 batches of water extracts had three common chromatographic peaks, namely peak 2, peak 4, and peak 6. Compared with the results of the differentiation of medicinal materials, water extracts of different varieties can also be distinguished according to the number of chromatographic peaks. The water extract of Cynanchum chinense can also be distinguished from other types of water extracts according to peak 11, which is the characteristic component of Cynanchum chinense.

[0208] In summary, the characteristic spectrum of Cynanchum chinense established by the method of the present application can effectively characterize its chemical composition, can be effectively distinguished from other counterfeits, and has a certain specificity.

[0209] Comparative Example 1

[0210] This experiment investigates the effects of different chromatographic conditions (mobile phase, chromatographic column, column temperature, elution procedure, etc.) on the characteristic spectrum of Cynanchum cynanchum. The XCQ11 test solution in Example 1 was taken and the characteristic spectrum of Cynanchum cynanchum was determined using different chromatographic conditions. The test results are shown in Figure 2. Fig.16 The labels in the figure correspond to different comparative chromatographic conditions.

[0211] 1. Comparison of chromatographic conditions 1

[0212] High performance liquid chromatography (Arc, Waters Corporation); YMC Triart C18 chromatographic column (4.6×250 mm, 5 μm); methanol as mobile phase A, water as mobile phase B, gradient elution according to Table 14; column temperature of 25°C, flow rate of 0.60 ml per minute, detection wavelength of 274 nm.

[0213] Table 14 Gradient elution table

[0214]

[0215] 2. Comparison of chromatographic conditions 2

[0216] High performance liquid chromatograph (Arc, Waters Corporation); Agilent TC-C18 chromatographic column (4.6×250 mm, 5 μm), Agilent ZORBAX SB-C18 chromatographic column (4.6×250 mm, 5 μm), YMC Triart C18 chromatographic column (4.6×250 mm, 5 μm), Waters Xselect HSS T3 chromatographic column (4.6×250 mm, 5 μm); acetonitrile was used as mobile phase A, 0.1% phosphoric acid was used as mobile phase B, and gradient elution was performed according to Table 15; the column temperature was 40° C., the flow rate was 1.0 ml per minute, and the detection wavelength was 274 nm.

[0217] Table 15 Gradient elution table

[0218]

[0219] 3. Comparison of chromatographic conditions 3

[0220] Ultra-high performance liquid chromatography (H-class, Waters); Thermo Acclaim C18 chromatographic column (2.1×150 mm, 2.2 μm); acetonitrile as mobile phase A, water as mobile phase B, gradient elution according to Table 16; column temperature 25°C, flow rate 0.25 ml per minute, detection wavelength 274 nm. Figure 1 .

[0221] Table 16 Gradient elution table

[0222]

[0223] 4. Comparison of chromatographic conditions 4

[0224] Ultra-high performance liquid chromatography (H-class, Waters Corporation); ACE EXCEL Super C18 chromatographic column (2.1×100 mm, 1.7 μm); acetonitrile as mobile phase A, water as mobile phase B, gradient elution according to Table 17; column temperature of 25°C, flow rate of 0.30 ml per minute, detection wavelength of 274 nm.

[0225] Table 17 Gradient elution table

[0226]

[0227] 5. Comparison of chromatographic conditions 5

[0228] High performance liquid chromatography (Arc, Waters Corporation); Agilent ZORBAX Extend-C18 chromatographic column (4.6×250 mm, 5 μm); acetonitrile as mobile phase A, water as mobile phase B, gradient elution according to Table 18; column temperature of 25°C, flow rate of 1.0 ml per minute, detection wavelength of 274 nm.

[0229] Table 18 Gradient elution table

[0230]

[0231] 6. Comparison of chromatographic conditions

[0232] High performance liquid chromatography (Arc, Waters Corporation); YMC Triart C18 chromatographic column (4.6×250 mm, 5 μm); acetonitrile as mobile phase A, water as mobile phase B, gradient elution according to Table 19; column temperature of 25°C, flow rate of 1.0 ml per minute, detection wavelength of 274 nm.

[0233] Table 19 Gradient elution table

[0234]

[0235] 7. Comparison of chromatographic conditions

[0236] High performance liquid chromatography (Arc, Waters Corporation); YMC Triart C18 chromatographic column (4.6×250 mm, 5 μm); acetonitrile as mobile phase A, 0.1% glacial acetic acid as mobile phase B, gradient elution according to Table 20; column temperature of 25° C., flow rate of 0.8 ml per minute, detection wavelength of 274 nm.

[0237] Table 20 Gradient elution table

[0238]

[0239] The results show that, compared with the chromatographic conditions of the present application, the use of other different types of chromatographic columns, mobile phases and elution procedures, column temperatures, flow rates, etc., the chromatograms obtained do not achieve the effects of the present application in terms of the number of chromatographic peaks or the separation of the main chromatographic peaks (see the relevant figures in Examples 1-2 for details, such as Figure 6 , Figure 7 , Figure 8 , Fig. 9 , Fig.10 etc.). Use Welch The C18 chromatographic column (4.6×250mm, 2.7μm) is more suitable for separating the acetophenone and phenol components in Cynanchum cyrtonema; using a methanol-0.05% phosphoric acid mobile phase system, since the elution ability of methanol is lower than that of acetonitrile, it is more conducive to improving the separation of chromatographic peaks, while the phosphoric acid solution improves the responsiveness of some chromatographic peaks and increases the number of main chromatographic peaks.

[0240] The technical features of the above-mentioned implementation modes and examples can be combined in any appropriate manner. To make the description concise, not all possible combinations of the technical features in the above-mentioned implementation modes and examples are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0241] The above-described embodiments only express several implementation methods of the present application, but they cannot be understood as limiting the scope of the patent application. It should be pointed out that, for those of ordinary skill in the art, without departing from the concept of the present application, several variations and improvements can also be made, which all belong to the protection scope of the present application. In addition, it should be understood that after reading the above-mentioned teaching content of the present application, those skilled in the art can make various changes or modifications to the present application, and the equivalent forms obtained also fall within the protection scope of the present application. It should also be understood that the technical solutions obtained by those skilled in the art on the basis of the technical solutions provided in the present application through logical analysis, reasoning or limited experiments are all within the protection scope of the claims attached to the present application. Therefore, the protection scope of the patent of the present application shall be based on the attached claims, and the description and drawings may be used to explain the contents of the claims.

Claims

1. A method for constructing a characteristic spectrum of Cynanchum chinense or its aqueous extract, It is characterized in that The steps include: Providing a test solution, the step of providing the test solution comprising: taking a test sample, adding a first extracting solution to perform a first extraction, separating the solid and the liquid to obtain a liquid, adding a second extracting solution to the obtained liquid to perform a second extraction, Wherein, the test sample is selected from one or both of Cynanchum chinense and water extract of Cynanchum chinense. The first extraction liquid includes water, the first extraction method includes ultrasound, The second extracting solution includes ether, and the second extraction method includes extraction; Providing a reference solution, wherein the reference substance in the reference solution includes a p-hydroxyacetophenone standard; The test solution and the reference solution were respectively subjected to high performance liquid chromatography analysis. The conditions of the HPLC analysis include: using methanol as mobile phase A and using a phosphoric acid aqueous solution with a volume concentration of 0.04% to 0.06% as mobile phase B for gradient elution. The gradient elution procedure includes: from 0 to 5 minutes, the volume percentage of the mobile phase A is maintained at 14%, from 5 minutes to 10 minutes, the volume percentage of the mobile phase A is increased from 14% to 20%, from 10 minutes to 60 minutes, the volume percentage of the mobile phase A is maintained at 20%, and from 60 minutes to 65 minutes, the volume percentage of the mobile phase A is increased from 20% to 70%.

2. The method for constructing the characteristic spectrum according to claim 1, It is characterized in that The conditions of the HPLC analysis also include at least one of the following characteristics: (1) The chromatographic column is filled with octadecylsilane bonded silica gel, (2) the column temperature is 28°C to 32°C, (3) the detection wavelength is 270 nm to 280 nm, (4) the flow rate of the mobile phase is 0.55 mL / min to 0.65 mL / min, and (5) the injection volume is 4 μl to 6 μl.

3. The method for constructing a characteristic spectrum according to claim 1, It is characterized in that In the step of providing a test solution: The ultrasonic power is 200W-400W, the frequency is 30kHz-50kHz, and / or The solid-liquid separation method includes centrifugation, and further, the centrifugal speed is 3000-5000 rpm, and / or The weight-to-volume ratio of the test sample to the first extract is selected from: 0.4-0.6 g / 25 mL or 2-4 g / 25 mL, and / or The volume ratio of the liquid obtained by the solid-liquid separation to the second extract is 25:(40-60).

4. The method for constructing a characteristic spectrum according to any one of claims 1 to 3, It is characterized in that The water extract of the Cynanchum chinense medicinal material includes a standard decoction of the Cynanchum chinense medicinal material and a Chinese medicine formula granule of the Cynanchum chinense medicinal material.

5. The method for constructing a characteristic spectrum according to claim 4, It is characterized in that The water extract of the Radix Cynanchum wilfordii medicinal material is prepared by the following preparation steps: Take a Radix Cynanchum Radix and soak it in water, add a first solvent to perform a first decoction, wherein the weight ratio of the first solvent to the Radix Cynanchum Radix is ​​(10-12):1, filter to obtain a first filtrate and a filter residue, add a second solvent to the filter residue to perform a second decoction, wherein the weight ratio of the second solvent to the Radix Cynanchum Radix is ​​(8-10):1, filter to obtain a second filtrate, and combine the first filtrate and the second filtrate; Wherein, the first solvent is water, and the first decoction time is 20min to 30min; The second solvent is water, and the second decoction time is 10 min to 20 min.

6. The method for constructing a characteristic spectrum according to any one of claims 1 to 3, It is characterized in that The characteristic spectrum of the Cynanchum chinense medicinal material or its water extract constructed includes 11 common peaks. Among them, taking peak 7 as a reference, the characteristic peaks and their relative retention times are as follows: peak 1: 0.37±10%, peak 2: 0.59±10%, peak 3: 0.67±10%, peak 4: 0.76±10%, peak 5: 0.86±10%, peak 6: 0.91±10%, peak 8: 1.37±10%, peak 9: 1.53±10%, peak 10: 1.70±10%, peak 11: 1.85±10%, Among them, peak 2 is p-hydroxybenzoic acid, peak 4 is vanillic acid, peak 7 is p-hydroxyacetophenone, peak 8 is isovillabite, peak 9 is 2,3-dihydroxy-4-methoxyacetophenone, peak 10 is 2,4-dihydroxyacetophenone, and peak 11 is 2,5-dihydroxy-4-methoxyacetophenone.

7. Identification method of Cynanchum chinense or its water extract, It is characterized in that The steps include: Providing a solution of the substance to be tested, wherein the step of providing the solution of the substance to be tested comprises: taking the substance to be tested, adding a first extracting solution to perform a first extraction, performing solid-liquid separation to obtain a liquid, and adding a second extracting solution to the obtained liquid to perform a second extraction, Wherein, the analyte is selected from one or both of Cynanchum chinense and its water extract, The first extraction liquid includes water, the first extraction method includes ultrasound, The second extracting solution includes ether, and the second extraction method includes extraction; Take a standard of Cynanchum chinense or its aqueous extract, prepare a characteristic spectrum of the standard and a characteristic spectrum of the object to be tested according to the method for constructing a characteristic spectrum according to any one of claims 1 to 6, compare the characteristic spectrum of the standard with the characteristic spectrum of the object to be tested, The conditions of the HPLC analysis include: using methanol as mobile phase A and using a phosphoric acid aqueous solution with a volume concentration of 0.04% to 0.06% as mobile phase B for gradient elution. The gradient elution procedure includes: from 0 to 5 minutes, the volume percentage of the mobile phase A is maintained at 14%, from 5 minutes to 10 minutes, the volume percentage of the mobile phase A is increased from 14% to 20%, from 10 minutes to 60 minutes, the volume percentage of the mobile phase A is maintained at 20%, and from 60 minutes to 65 minutes, the volume percentage of the mobile phase A is increased from 20% to 70%.

8. The identification method according to claim 7, It is characterized in that The conditions of the HPLC analysis also include at least one of the following characteristics: (1) The chromatographic column is filled with octadecylsilane bonded silica gel, (2) the column temperature is 28°C to 32°C, (3) the detection wavelength is 270 nm to 280 nm, (4) the flow rate of the mobile phase is 0.55 mL / min to 0.65 mL / min, and (5) the injection volume is 4 μl to 6 μl.

9. The identification method according to claim 7, It is characterized in that In the step of providing the test solution: the power of the ultrasound is 200W to 400W, the frequency is 30kHz to 50kHz, and / or The solid-liquid separation method includes centrifugation, and further, the centrifugal speed is 3000-5000 rpm, and / or The weight-to-volume ratio of the test sample to the first extract is selected from 0.4-0.6 g / 25 mL or 2-4 g / 25 mL, and / or The volume ratio of the liquid obtained by the solid-liquid separation to the second extract is 25:(40-60).

10. The identification method according to any one of claims 7 to 9, It is characterized in that The water extract of the Cynanchum chinense medicinal material includes a standard decoction of the Cynanchum chinense medicinal material and a Chinese medicine formula granule of the Cynanchum chinense medicinal material.

11. The identification method according to claim 10, It is characterized in that The water extract of the Radix Cynanchum wilfordii medicinal material is prepared by the following preparation steps: Take a Radix Cynanchum Radix and soak it in water, add a first solvent to perform a first decoction, wherein the weight ratio of the first solvent to the Radix Cynanchum Radix is ​​(10-12):1, filter to obtain a first filtrate and a filter residue, add a second solvent to the filter residue to perform a second decoction, wherein the weight ratio of the second solvent to the Radix Cynanchum Radix is ​​(8-10):1, filter to obtain a second filtrate, and combine the first filtrate and the second filtrate; Wherein, the first solvent is water, and the first decoction time is 20 to 30 minutes; The second solvent is water, and the second decoction time is 10 to 20 minutes.